Published 11 August 2009, doi:10.1136/bmj.b3066
Cite this as: BMJ 2009;339:b3066

Editorials

Risk of suicidal behaviour in adults taking antidepressants

Increased risk is probably restricted to younger people and varies greatly between individual medicines

The first 150 words of the full text of this article appear below.

Antidepressant drugs currently carry warnings of the possibility of increased suicidal ideation and behaviour during treatment, especially in younger patients. In the linked meta-analysis (doi:10.1136/bmj.b2880), Stone and colleagues report on the possible link between the risk of suicide and antidepressants using data on individual patients from placebo controlled trials.¹ This analysis of 372 placebo controlled antidepressant trials and nearly 100 000 patients found that the association between antidepressant drugs and the incidence of reported suicidal behaviour is strongly related to age. The risk was raised in people under 25, not affected in those aged 25-64, and reduced in those aged 65 and older. The analysis also found differences in risk between drugs.

This analysis is not new—it was published fully on the Food and Drug Administration (FDA) website more than two years ago.² It was widely covered at the time in the international medical press and led to . . . [Full text of this article]

¹ University of Oxford, Warneford Hospital, Oxford OX3 7JX, ² Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico GB Rossi, 37134 Verona, Italy

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration

Marc Stone, Thomas Laughren, M Lisa Jones, Mark Levenson, P Chris Holland, Alice Hughes, Tarek A Hammad, Robert Temple, and George Rochester
BMJ 2009 339: b2880. [Abstract] [Full Text] [PDF]

Suicide, depression, and antidepressants

Andrea Cipriani, Corrado Barbui, and John R Geddes
BMJ 2005 330: 373-374. [Extract] [Full Text] [PDF]

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

David Gunnell, Julia Saperia, and Deborah Ashby
BMJ 2005 330: 385. [Abstract] [Full Text] [PDF]

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

Dean Fergusson, Steve Doucette, Kathleen Cranley Glass, Stan Shapiro, David Healy, Paul Hebert, and Brian Hutton
BMJ 2005 330: 396. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Barbui, C., Cipriani, A., Furukawa, T. A, Salanti, G., Higgins, J. P T, Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M, Geddes, J. R (2009). Making the best use of available evidence: the case of new generation antidepressants: A response to: Are all antidepressants equal?. Evid. Based Ment. Health 12: 101-104 [Full text]  

Rapid Responses:

Read all Rapid Responses

Risk of Suicidality with SSRIs - Where do we go from here?

Malcolm VandenBurg
bmj.com, 22 Aug 2009 [Full text]

Online poll

Find out more here>> and here>>